A Biomimetic Membrane Device That Modulates the Excessive Inflammatory Response to Sepsis
Open Access
- 14 April 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (4), e18584
- https://doi.org/10.1371/journal.pone.0018584
Abstract
Septic shock has a clinical mortality rate approaching fifty percent. The major clinical manifestations of sepsis are due to the dysregulation of the host's response to infection rather than the direct consequences of the invading pathogen. Central to this initial immunologic response is the activation of leukocytes and microvascular endothelium resulting in cardiovascular instability, lung injury and renal dysfunction. Due to the primary role of leukocyte activation in the sepsis syndrome, a synthetic biomimetic membrane, called a selective cytopheretic device (SCD), was developed to bind activated leukocytes. The incorporation of the SCD along an extracorporeal blood circuit coupled with regional anticoagulation with citrate to lower blood ionized calcium was devised to modulate leukocyte activation in sepsis. Laboratory investigation. University of Michigan Medical School. Pigs weighing 30-35 kg. To assess the effect of the SCD in septic shock, pigs were administered 30×1010 bacteria/kg body weight of Escherichia coli into the peritoneal cavity and within 1 hr were immediately placed in an extracorporeal circuit containing SCD. In this animal model, the SCD with citrate compared to control groups without the SCD or with heparin anticoagulation ameliorated the cardiovascular instability and lung sequestration of activated leukocytes, reduced renal dysfunction and improved survival time compared to various control groups. This effect was associated with minimal elevations of systemic circulating neutrophil activation. These preclinical studies along with two favorable exploratory clinical trials form the basis of an FDA-approved investigational device exemption for a pivotal multicenter, randomized control trial currently underway.This publication has 35 references indexed in Scilit:
- A Selective Cytopheretic Inhibitory Device to Treat the Immunological Dysregulation of Acute and Chronic Renal FailureBlood Purification, 2010
- Suppression and Recovery of LPS-Stimulated Monocyte Activity After Trauma is Correlated With Increasing Injury Severity: A Prospective Clinical StudyThe Journal of Trauma and Acute Care Surgery, 2009
- Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infectionsProceedings of the National Academy of Sciences of the United States of America, 2009
- Measurement of equine myeloperoxidase (MPO) activity in synovial fluid by a modified MPO assay and evaluation of joint diseases – An initial case studyResearch in Veterinary Science, 2008
- Heparins Increase Endothelial Nitric Oxide Bioavailability by Liberating Vessel-Immobilized MyeloperoxidaseCirculation, 2006
- Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shockCritical Care Medicine, 2003
- Neutrophil AbnormalitiesPediatrics in Review, 2003
- The Pathophysiology and Treatment of SepsisThe New England Journal of Medicine, 2003
- Calcium and signal transduction in granulocytesCurrent Opinion in Hematology, 1996
- Regional Citrate Anticoagulation for Hemodialysis in the Patient at High Risk for BleedingThe New England Journal of Medicine, 1983